| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 03/14/2013 | WO2013036298A1 Allergen-specific induced tolerogenic dendritic cells for allegy therapy |
| 03/14/2013 | WO2013036293A1 Dendritic cell subsets for generating induced tolerogenic dendritic cells and related compositions and methods |
| 03/14/2013 | WO2013034795A1 Peptide secreted by lactobacillus plantarum with immunomodulating function |
| 03/14/2013 | WO2013033862A1 4-substituted-(3-substituted-1h-pyrazole-5-amino)-pyrimidine derivatives having activity of inhibiting protein kinase and use thereof |
| 03/14/2013 | WO2012178160A3 Materials and methods for modulating immune responses |
| 03/14/2013 | WO2012115715A3 Compositions with enhanced immunogenicity and/or reduced reactogenicity and methods of use |
| 03/14/2013 | US20130067607 Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof |
| 03/14/2013 | US20130066069 Processes for preparing substituted pyrimidines |
| 03/14/2013 | US20130066058 Use of Antisense Oligonucleotides or siRNA to Suppress Expression of eIF-5A1 |
| 03/14/2013 | US20130065943 Compositions and methods for inhibiting expression of cd45 gene |
| 03/14/2013 | US20130065905 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine |
| 03/14/2013 | US20130065902 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators |
| 03/14/2013 | US20130065899 Heteroaryl compounds and uses thereof |
| 03/14/2013 | US20130065897 Compounds, preparation and uses thereof |
| 03/14/2013 | US20130065894 6-(4-HYDROXY-PHENYL)-3-STYRYL-1H-PYRAZOLO[3,4-b]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS |
| 03/14/2013 | US20130065889 2,5-disubstituted arylsulfonamide ccr3 antagonists |
| 03/14/2013 | US20130065885 Oral therapeutic compound delivery system |
| 03/14/2013 | US20130065883 Triazolo [4, 5- B] Pyridin Derivatives |
| 03/14/2013 | US20130065882 VLA-4 inhibitory drug |
| 03/14/2013 | US20130065881 Tricyclic Compounds for Use as Kinase Inhibitors |
| 03/14/2013 | US20130065880 Compounds as tyrosine kinase modulators |
| 03/14/2013 | US20130065860 3-(4-(5-phenyl-1 ,2,4-oxadiazol-3-yl)phenoxy)propan-2-ol derivatives as sphingosine-1 phosphate receptors modulators |
| 03/14/2013 | US20130065858 Compounds useful as raf kinase inhibitors |
| 03/14/2013 | US20130065842 COMPOUNDS AS RORyT MODULATORS AND USES THEREOF |
| 03/14/2013 | US20130065839 Treatment of t-cell mediated diseases |
| 03/14/2013 | US20130065838 Sap variants and their use |
| 03/14/2013 | US20130065818 Arylamide Compounds And Compositions And Uses Thereof |
| 03/14/2013 | US20130065816 Analogs of pituitary adenylate cyclase-activating polypeptide (pacap) and methods for their use |
| 03/14/2013 | US20130064910 Composition for treating atopic dermatitis comprising extracts of bamboo and scutellaria |
| 03/14/2013 | US20130064904 Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof |
| 03/14/2013 | US20130064864 Submicron particles to decrease transfusion |
| 03/14/2013 | US20130064859 Combinatorial vitamin d and probiotic therapy for inflammatory bowel disease |
| 03/14/2013 | US20130064858 Polysaccharide suitable to modulate immune response |
| 03/14/2013 | US20130064857 Methods and materials for making and using vaccines |
| 03/14/2013 | US20130064856 Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization |
| 03/14/2013 | US20130064854 Methods of treating allergies with substantially phenol-free carriers |
| 03/14/2013 | US20130064850 Using Modified Plasmids to Suppress Antibiotic Resistant Pathogens |
| 03/14/2013 | US20130064848 Heterochain aliphatic poly-n-oxide copolymers and vaccinating agents and drugs based thereon |
| 03/14/2013 | US20130064846 Neisserial antigens |
| 03/14/2013 | US20130064842 Compositions and Methods for Detection of Antibodies Specific for Anaplasma phagocytophilum (Aph) and Anaplasma platys (Apl) |
| 03/14/2013 | US20130064841 Immunogenic compositions against human progastrin peptides |
| 03/14/2013 | US20130064839 Method of rapidly producing improved vaccines for animals |
| 03/14/2013 | US20130064837 Integrin alpha-v beta8 neutralizing antibody |
| 03/14/2013 | US20130064831 Immunotherapeutic dosing regimens and combinations thereof |
| 03/14/2013 | US20130064822 Humanized anti-egfl7 antibodies and methods using same |
| 03/14/2013 | US20130064819 Biomarkers |
| 03/14/2013 | US20130064818 Use of immunesuppressant receptor |
| 03/14/2013 | US20130064817 Engineered anti-il-23r antibodies |
| 03/14/2013 | US20130064816 TNF-alpha ANTAGONISTS AND METHOTREXATE IN THE TREATMENT OF TNF-MEDIATED DISEASE |
| 03/14/2013 | US20130064813 Protein Belonging to the TNF Superfamily Involved in Signal Transduction, Nucleic Acids Encoding Same and Methods of Use Thereof |
| 03/14/2013 | US20130064801 Cellular Compositions and Methods of Making and Using Them |
| 03/14/2013 | US20130064795 Immune modulation |
| 03/14/2013 | US20130064788 Il-17 family cytokine compositions and uses |
| 03/14/2013 | US20130064777 Surfactant-free water-free foamable compositions, breakable foams and gels their uses |
| 03/14/2013 | US20130064760 Method for Treating Crohn's Disease By Administering An Anti-IL-12 Antibody |
| 03/14/2013 | CA2848163A1 Nanoemulsion respiratory syncytial virus (rsv) subunit vaccine |
| 03/14/2013 | CA2848129A1 3-(4-(5-phenyl-1,2,4-oxadiazol-3-yl)phenoxy)propan-2-ol derivatives as sphingosine-1 phosphate receptors modulators |
| 03/14/2013 | CA2846870A1 A conditional replicating cytomegalovirus as a vaccine for cmv |
| 03/14/2013 | CA2844175A1 Lipophilic dopamine derivatives and their use |
| 03/13/2013 | EP2567976A2 Antibodies against CD38 for treatment of multiple myeloma |
| 03/13/2013 | EP2567963A1 Trehalose compound, method for producing same, and pharmaceutical product containing the compound |
| 03/13/2013 | EP2566889A1 Antibody composition obtained by fractionation of plasma immunoglobulins affinity chromatography on a sambucus nigra affinity column |
| 03/13/2013 | EP2566878A1 Methods of inhibiting inflammation and inflammatory diseases using gal-3bp (btbd17b, lgals3bp, galectin-3 binding protein, mac-2 binding protein) |
| 03/13/2013 | EP2566876A1 Methods and compounds for inhibiting glycosyltransferases |
| 03/13/2013 | EP2566866A1 4 substituted pyrazolopyrimidines useful as pkc-theta inhibitors |
| 03/13/2013 | EP2566861A1 Modulators of fatty acid amide hydrolase |
| 03/13/2013 | EP2566518A1 Dendritic cell immunoreceptors (dcir)-mediated crosspriming of human cd8+ t cells |
| 03/13/2013 | EP2566516A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases |
| 03/13/2013 | EP2566515A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases |
| 03/13/2013 | EP2566477A1 Amino-quinolines as kinase inhibitors |
| 03/13/2013 | EP2566473A1 Dosage regimen of diaryl sulfide derivatives |
| 03/13/2013 | EP2566470A1 Treatment of autoimmune diseases |
| 03/13/2013 | CN1984672B Modulation of NKG2D |
| 03/13/2013 | CN1578785B Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 03/13/2013 | CN102971340A Antibodies with enhanced or suppressed effector function |
| 03/13/2013 | CN102971324A MTOR selective kinase inhibitors |
| 03/13/2013 | CN102971300A Crystalline forms for 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said forms |
| 03/13/2013 | CN102971291A Novel amide derivative and use thereof as medicine |
| 03/13/2013 | CN102971286A New cathepsin S protease inhibitors, useful in the treatment of e.g. autoimmune disorders, allergy and chronic pain conditions |
| 03/13/2013 | CN102965257A Health-preservation kidney-tonifying and wind-dispelling wine and preparation method thereof |
| 03/13/2013 | CN102965255A Healthcare wine for enhancing immunity |
| 03/13/2013 | CN102964465A Method for extracting angelica polysaccharide by use of angelica dregs |
| 03/13/2013 | CN102964461A Auxiliary extraction method of biological enzyme for improving dissolution rate of dendrobe bioactive polysaccharide |
| 03/13/2013 | CN102964459A Lentinan calcium complex, and preparation method and application thereof |
| 03/13/2013 | CN102964427A Bioactive polypeptide QEPVL, and preparation and application thereof |
| 03/13/2013 | CN102964425A Conjugates of Docetaxel and simplified MDP analogue and anti-tumor effect |
| 03/13/2013 | CN102964384A Adefovir dipivoxil gallic acid eutectic, and preparation method and composition thereof |
| 03/13/2013 | CN102964303A Sinomenine derivate and preparation method and application thereof |
| 03/13/2013 | CN102961735A Application of regulatory peptides GM21 in preparation of medicine for adjusting goat immune function |
| 03/13/2013 | CN102961695A Acanthopanan trifoliatus (L.) Merr. health care product and preparation method thereof |
| 03/13/2013 | CN102961551A Damp clearing composition |
| 03/13/2013 | CN102961545A Traditional Chinese medicine composition for treating scleroderma |
| 03/13/2013 | CN102961532A Traditional Chinese medicine for treating anaphylactoid purpura |
| 03/13/2013 | CN102961530A Pure traditional Chinese medicine composition for enhancing immunity and preparation method thereof |
| 03/13/2013 | CN102961503A Medicinal composition for improving sleep and strengthening immunity and preparation method thereof |
| 03/13/2013 | CN102961478A Anti-inflammatory and anti-allergic composition and preparation method for same |
| 03/13/2013 | CN102961427A Wild chrysanthemum extraction process and measuring method for total flavonoids in wild chrysanthemums |
| 03/13/2013 | CN102961425A Anti-allergic medicine with asparagus lettuce being effective component |
| 03/13/2013 | CN102961424A Panax notoginseng polysaccharide extract and preparation method, preparations and applications thereof |
| 03/13/2013 | CN102961420A Preparation method of pokeberry root total saponins |